St. Cloud Surgical Center is First ASC in U.S. to Utilize Xenex Germ-Zapping Robot to Disinfect Operating Rooms & Enhance Patient Safety more

4 cheap small cap stocks I’ve got my eye for Christmas more

Southern Biologics Network Established to Create Biologics Faster and Less Expensively more

Morningside Ministries at the Manor is the First Skilled Nursing Facility in Texas to Protect Residents with Xenex Germ-Zapping Robot more

RBA to cut rates in 2015: Still want to invest in term deposits? more

Can robots help stop the Ebola outbreak? more

Robots Help Fight Ebola more

South Florida Hospital Unveils Ebola-Zapping Robot more

Sonoma Valley Hospital uses robot to kill germs more

Robots go to war against Ebola more

New iTraumaCare CEO to pursue big growth more

UAB and SRI have plans to spinoff more success more

Launch of Galderma's new acne products more

iTraumaCare’s new CEO to help company secure new funding more

U.S. Air Force Hospital Langley Adds Xenex Ebola-Zapping Robot to Inventory more

Forthcoming Acne Treatment Made With Exclusive (And Sustainable) East Indian Sandalwood Oil

East Indian sandalwood trees are tropical trees that contain fragrant and medicinal oil, revered and used throughout Asia in everything from traditional Chinese medicine to religious ceremonies and worship. In India, where the tree bears such significance, it’s believed to “lift the spirits to heaven,” thus its frequent use during funerals and cremation. It’s also a tree that’s become endangered in recent years due to poaching and overharvesting. That is, until the world’s leading sandalwood supplier TFS cultivated an essential sandalwood forest the size of Manhattan in Northern Australia 15 years ago. Fast forward to present day and the medicinal oil will be licensed and sustainably supplied to global dermatology company Galderma in an effort to finally soothe mild-to-moderate acne sufferers.

The daily, three-step acne regimen is called Benzac Acne Solutions, and it’s slated to grace Galderma’s best-selling product Cetaphil and topical acne treatments on Jan. 2, 2015. Each product is non-comedogoenic (tends to not clog pores) and made with vegan, cruelty-free, acne-fighting ingredients, including Galderma’s exclusive share of sandalwood oil, salicyclic acid, Kakadu plum, honeysuckle, zinc, onion extract, and lemon myrtle. “We know now, through science, the pimple doesn’t pop up overnight,” Dana Blick, marketing and brand manager for Benzac, told an audience of editors gathered for a launch presentation at the Gansevoort Hotel on Park Avenue in New York. “It’s been happening under your skin for a couple weeks before it actually surfaces. …We’re here with Benzac to start changing that conversation, that as soon as our pimple goes away, we [can’t] go back to old cleanser or quit spot treatment. [Maintenance prevents] acne from coming back.”

Studies testing Benzac's solutions find it to be a clinically proven regimen with acne sufferers seeing results in two weeks. After eight weeks, photos of one tester showed minimal to no traces of acne. Even if a person has oily, combination skin, and they occasionally breakout, Benzac is a viable option for relief. “It’s an incredible blend of natural ingredients that are anti-inflammatory, anti-microbial, and work to calm and soothe skin while you’re treating your acne,” Blick said.

Galderma reported 40 to 50 million Americans struggle with acne today, but Dr. Jeanine Downie, a board-certified dermatologist and director of Image Dermatology, believes that number is much closer to 100 million Americans. The condition is grossly underreported, she said. What’s worse is there are over 1,300 different types of acne treatments, both over-the-counter and prescribed by doctors and dermatologists. And unfortunately, most don’t work overnight. “A medical-grade treatment, like a cyst injection, will,” Downie said, “but many things for acne don’t work. Or, if pimples clear up, their skin is still dry, irritated, and peeling.”

This, apparently, won’t be the case with Benzac. Combined with science to give you natural, good-looking, healthy skin, its products will apparently leave you with predictable skin, which you want, Blick said. You want to be able to count on your skin looking good and fresh and glowing every morning. Benzac will also leave you with good faith. TFS uses renewable energy to create sandalwood oil, and the recreated forest has made it possible for multiple species of birds and wild life to thrive. Next, TFS will work with Nobel Peace Prize winner Kailash Satyarthi to breathe life into an area in India where sandalwood used to grow.

What's Downie's final say on the product? "I like the fact I can tell my clients this product is vegan. Maybe I’ll combine it with a prescription product, maybe I won’t, but some of my patients don’t want to deal with anything but something vegan. In general, mild to moderate [treatments] might also move more toward sustainability and natural ingredients.”

Source: http://www.medicaldaily.com back

Sonoma Valley Hospital Acquires Xenex Germ-Killing Robot to Enhance Patient Safety more

Robot fights germs at Sharp Chula Vista Medical Center more

Xenex updates protocols for germ-zapping robots in response to Ebola threat more

How do we get rid of the endotoxins? Birmingham's  has the solution more

Medical Device ® Positions New Leader for Next-Level Growth more

The Xenex robot at South Shore Hospital featured on an Xploration Earth more

Germ-zapping robot Gigi sets its sights on Ebola more

Morningside Ventures leads a Series B round for DNAtrix more

StemBioSys secures new research space at BioBridge Global more

Birmingham's Soluble Therapeutics acquires Seattle company Dilyx Biotechnology more

Company invents germ-zapping robot more

Xenex Congratulates Houston Cancer Hospital more

Australian grown Indian Sandalwood timber attracts lucrative Asian markets more

DNATRIX ANNOUNCES TREATMENT OF FIRST PATIENT WITH DNX-2401 more

Targeted Technology raises more than $40 million more

Reducing Healthcare Associated Infections (HAIs): Not All UV Light is the Same more

Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO more

Three Birmingham companies recognized in PwC report more

Former Kinetic Concepts Inc. CEO to lead StemBioSys more

International dermatology company Galderma confirmed more

AUSTRALIAN Sandalwood producer TFS Corporation will supply oil more

San Antonio luring biotech firms with venture capital more

Biotech firm secures nearly $5 million in funding, is relocating to San Antonio more

Birmingham is on the front lines of medical research: take a look at this incredible biotech startup more

Germ-Zapping Robots Fight C. diff and MRSA at Mercy Health Saint Mary's more

Milford hospital enlists robots in war against infections more

Xenex Testifies About UV Room Disinfection Technology Effectiveness to U.S. House of Representatives more

Western Pa. hospitals test robot using ultraviolet rays to kill bacteria more

Xenex Demonstrates UV Room Cleaning System’s Effectiveness in Reducing Hospital Acquired Infections more

TFS flags record full-year profit more

Sweet scented sandalwood flavour of month more

House committee looks for new technology in Veterans Affairs hospitals more

FDA grants fast track status to drug DNX-2401 for recurrent Glioblastoma more

CEO shakeup at San Antonio biotech company StemBioSys more

First harvest to be completed in June more

BiO2 Medical Enrolls Subjects in the New U.S. FDA Early Feasibility Pilot Study for the Angel® Catheter more

San Antonio biotech firm readies skin treatment for distribution more

ViroXis Gets Approval To Initiate FDA Phase 2 Study For Molluscum Contagiosum more

Medical technologies conference announces speaker lineup more

Australian sandalwood sells for millions more

Sandalwood exports as good as gold more

Santalis Pharmaceuticals Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize OTC Dermatology Products more

ViroXis Corporation Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize an OTC Dermatology Product more

DNAtrix Awarded $10.8 Million Grant by the Cancer Prevention and Research Institute of Texas more

ViroXis Corporation Achieves Key Clinical Milestones more

There are growing concerns about the threat of an antibiotic crisis caused by the spread of drug-resistant superbugs. Those concerns could result in more